Page 5 - பார்கின்சன் படிப்பு குழு நிர்வாகி குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பார்கின்சன் படிப்பு குழு நிர்வாகி குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பார்கின்சன் படிப்பு குழு நிர்வாகி குழு Today - Breaking & Trending Today

Annovis Bio, Inc.: Annovis Bio Announces Positive Phase 2 Data - Interim Data Shows ANVS401 Improves Speed and Coordination in Parkinson's Patients


(2)
Berwyn, Pennsylvania (Newsfile Corp. - March 16, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, today announced results of an interim analysis from a double-blind, placebo-controlled study of ANVS401, its lead drug candidate for the treatment of PD and AD. Patients speed and coordination scores both improved following 25 days of ANVS401 treatment, with no serious adverse events.
Dr. Maria L. Maccecchini, CEO of Annovis Bio, explained: We set up this study to measure the toxic cascade leading to nerve cell death and loss of function and its reversal. The study was powered to investigate a difference of 20 to 25 percent in biomarker levels, not to demonstrate efficacy, making this data that much more significant. ....

United States , Marial Maccecchini , Annovis Bio , Exchange Commission , Pennsylvania Newsfile Corp , Annovis Bio Inc , Redchip Companies Inc , Down Syndrome , Annual Report , ஒன்றுபட்டது மாநிலங்களில் , பரிமாற்றம் தரகு , கீழ் நோய்க்குறி , ஆண்டு அறிக்கை ,